NASDAQ · RCEL
Avita Medical Inc.
$16.71+$0.21 (+1.27%)
Avita Medical Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.12% below the high.
Loading market information…
NASDAQ · QIPT · USD
Stock price, earnings
Quote as of Mar 17, 2026, 01:30 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Quipt Home Medical Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Quipt Home Medical Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Quipt Home Medical Corp., headquartered in Wilder, Kentucky, delivers essential medical devices and supplies directly to patients' homes across the United States. The company is dedicated to supporting individuals managing various chronic health conditions, such as cardiac and pulmonary diseases, sleep disorders, and reduced mobility, by supplying durable and respiratory medical equipment. Their extensive product catalog includes vital respiratory aids like oxygen concentrators, nebulizers, CPAP and BiPAP machines, and ventilator systems. Additionally, Quipt offers a broad selection of mobility assistance devices, including power wheelchairs, walkers, canes, crutches, and patient lifts. Other offerings span hospital beds, bariatric equipment, bathroom safety products, and wound care supplies. The company also provides rental options for specific respiratory apparatus. Established in 1993, the organization was known as Protech Home Medical Corp. until it rebranded to Quipt Home Medical Corp. in May 2021.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:09 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| $38.96M-56.45% vs estimate |
| Q3 2024 | Aug 14, 2024 | -$0.04-166.67% vs estimate | $46.79M-28.35% vs estimate |
|---|
| Q2 2024 | May 15, 2024 | -$0.03-549.35% vs estimate | $45.11M-32.55% vs estimate |
|---|
THE ANALYST VIEW
2 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$16.71+$0.21 (+1.27%)
Avita Medical Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.12% below the high.
$19.09$0.00 (0.0%)
Fonar Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.34% below the high.
$2.69+$0.08 (+3.07%)
Apyx Medical Corporation’s quoted price sits in the lower half of its reported 52-week range, 47.05% below the high.
$1.14$0.00 (0.0%)
Vivani Medical, Inc.’s quoted price sits in the lower half of its reported 52-week range, 36.67% below the high.
$3.98-$0.08 (-1.97%)
Coya Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 39.88% below the high.
$0.74-$0.04 (-5.23%)
Hyperfine, Inc.’s quoted price sits in the lower half of its reported 52-week range, 61.67% below the high.
$0.29+$0.00 (+1.54%)
Xtant Medical Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 69.43% below the high.
$0.27-$0.01 (-2.43%)
DocGo Inc.’s quoted price sits in the lower half of its reported 52-week range, 76.66% below the high.
